Seed Life Science Companies

Platform Therapeutics develops therapies for chemotherapy toxicities and dialysis-related muscle cramps.

Codebreaker Labs builds causal genomics data by experimentally mapping genetic variants to cellular effects, powering AI for medicine.

AC BioScience is a biotech company that develops personalized molecular therapies designed for cancer patients.

We are building a new pipeline to discovery and test drugs

4M Therapeutics Inc. (4MTx) develops therapies for central nervous system (CNS) disorders with blockbuster potential.

Jellatech is a B2B biotech business that produces pure, animal-free collagen and gelatin.

Cisterna Biologics is a technology company that aims to solve the biotech industry's main challenges in developing mRNA-based therapeutics

Single Pass is a developer of a disposable bipolar electrocautery device.

Deliverome Bio builds an open atlas of human surface proteins for targeted delivery research.

Alucio is a software startup that transforms scientific exchange and treatment access for the life sciences industry.

LifeCyte Innovations develops therapies targeting chronic inflammation to slow age-related diseases, including AMD and cognitive decline.

Cerillo is a biotechnology company that removes artificial boundaries placed on researchers by traditional laboratory technologies.

Acenxion Biosystems is a privately funded company developing automated medical diagnostic systems for precision medicine.

Mirugen is a preclinical biotechnology company identifying the optimal set of cellular instructions to ask one cell type to become another.

Decentralized Autonomous Organisation funding personalized medicine research for life-altering diseases

We use innovative biotechnologies to develop fast, simple and accessible molecular testing solutions.

Consumer Science Company using biotech and AI to create plant-based bioactives for longevity, wellness, and sustainable health.

Amaroq Therapeutics is a biotech firm developing cancer therapies targeting long non-coding RNAs.

Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer(TM).

Revolver Therapeutics develops peptide therapeutics using a screening platform to target transcription factors for cancer treatment.

The Tokenised Cloud - Sustainable, Decentralised

Immitra Bio is a pioneer in next-generation gene therapy platforms.

Unlocking new contact lens capabilities through precision light-filtering innovation.

Wellcana is a biopharmaceutical company developing cannabinoid therapies to treat patients with a variety of medical conditions.

Cantai Therapeutics operates as a developer of drug candidates.